Canada Markets open in 13 mins

Gritstone bio, Inc. (GRTS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.1700+0.1000 (+4.83%)
At close: 04:00PM EDT
2.1900 +0.02 (+0.92%)
Pre-Market: 09:09AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.0700
Open2.1600
Bid2.2200 x 2200
Ask2.2700 x 1400
Day's Range2.1400 - 2.2500
52 Week Range2.0000 - 14.4200
Volume1,019,365
Avg. Volume1,326,035
Market Cap147.534M
Beta (5Y Monthly)0.03
PE Ratio (TTM)N/A
EPS (TTM)-1.0740
Earnings DateMar 11, 2022 - Mar 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.67
  • Simply Wall St.

    Are Institutions Heavily Invested In Gritstone bio, Inc.'s (NASDAQ:GRTS) Shares?

    The big shareholder groups in Gritstone bio, Inc. ( NASDAQ:GRTS ) have power over the company. Generally speaking, as a...

  • GlobeNewswire

    CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update

    -- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data evaluating self-amplifying mRNA (samRNA) vaccines against viruses expected over the next 18 months -- -- Recent presentations reinforce expertise in vaccine design and delivery and potential of Gritstone’s platform technologies in oncology and infectious diseases -- -- Cash, cash equivalents, marketable securities and restricted cash of $186.8 millio

  • GlobeNewswire

    Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update

    -- Clinical programs continue progressing, with multiple Phase 2 data catalysts from neoantigen oncology vaccine programs and additional human data evaluating self-amplifying mRNA (samRNA) vaccines against viruses expected over the next 18 months -- -- Recent presentations reinforce expertise in vaccine design and delivery and potential of Gritstone’s platform technologies in oncology and infectious diseases -- -- Cash, cash equivalents, marketable securities and restricted cash of $186.8 millio